Skip to content
Clinical Trials – home
Tanabe Pharma America Inc.
Sponsor

Tanabe Pharma America Inc.

United States 525 Washington Boulevard Suite 1100, 07310-2604, United States

About the sponsor

Tanabe Pharma America Inc. is involved in clinical research for Erythropoietic Protoporphyria and X-Linked Protoporphyria, rare porphyria disorders marked by heightened sensitivity to sunlight and painful cutaneous symptoms.

  • Sunlight-induced pain and skin symptoms
  • Phototoxicity management
  • Prodromal symptom control

The sponsor’s research focus includes adult and adolescent populations affected by light-triggered burning, tingling, itching, and stinging sensations.

About Specializations

Tanabe Pharma America Inc. runs clinical trials in conditions such as Porphyria non-acute, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Porphyria non-acute

Not recruiting

Study on the Safety and Tolerability of Oral Dersimelagon for Patients with Erythropoietic Protoporphyria or X-Linked Protoporphyria

InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dersimelagon Phosphate
  • Sponsor:Tanabe Pharma America Inc.

Porphyria non-acute

Not recruiting

Study on the Effects of Dersimelagon Phosphate for Adults and Adolescents with Erythropoietic Protoporphyria or X-Linked Protoporphyria

Investigational
Countries:BulgariaBulgaria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dersimelagon Phosphate
  • Sponsor:Tanabe Pharma America Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.